"Vancomycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
Descriptor ID |
D014640
|
MeSH Number(s) |
D09.400.420.925 D12.644.233.925
|
Concept/Terms |
Vancocin- Vancocin
- Vancocin HCl
- Vancomycin Lilly
- Vancocine
|
Below are MeSH descriptors whose meaning is more general than "Vancomycin".
Below are MeSH descriptors whose meaning is more specific than "Vancomycin".
This graph shows the total number of publications written about "Vancomycin" by people in this website by year, and whether "Vancomycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1996 | 2 | 1 | 3 |
1998 | 2 | 0 | 2 |
1999 | 2 | 1 | 3 |
2000 | 0 | 1 | 1 |
2002 | 1 | 1 | 2 |
2003 | 3 | 4 | 7 |
2004 | 0 | 2 | 2 |
2005 | 2 | 3 | 5 |
2006 | 4 | 3 | 7 |
2007 | 1 | 3 | 4 |
2008 | 2 | 3 | 5 |
2009 | 4 | 3 | 7 |
2010 | 0 | 2 | 2 |
2011 | 2 | 4 | 6 |
2012 | 3 | 6 | 9 |
2013 | 8 | 1 | 9 |
2014 | 2 | 2 | 4 |
2015 | 3 | 1 | 4 |
2016 | 2 | 9 | 11 |
2017 | 5 | 6 | 11 |
2018 | 4 | 4 | 8 |
2019 | 4 | 1 | 5 |
2020 | 4 | 4 | 8 |
2021 | 1 | 4 | 5 |
2022 | 3 | 5 | 8 |
2023 | 0 | 2 | 2 |
2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vancomycin" by people in Profiles.
-
Vancomycin nephrotoxicity: A comprehensive clinico-pathological study. PLoS One. 2024; 19(3):e0295136.
-
Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0162123.
-
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers. J Infect Dis. 2024 Jan 12; 229(1):273-281.
-
Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children. Pediatr Infect Dis J. 2023 06 01; 42(6):449-455.
-
Reply: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023 06 01; 77(6):E176-E177.
-
Neonatal antibiotics have long term sex-dependent effects on the enteric nervous system. J Physiol. 2022 10; 600(19):4303-4323.
-
Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection. Antimicrob Agents Chemother. 2022 08 16; 66(8):e0224421.
-
Antimicrobial Susceptibility Testing for Enterococci. J Clin Microbiol. 2022 09 21; 60(9):e0084321.
-
Epidemiology and variability in management of acute mastoiditis in children. Am J Otolaryngol. 2022 Sep-Oct; 43(5):103520.
-
A Vancomycin HPLC Assay for Use in Gut Microbiome Research. Microbiol Spectr. 2022 06 29; 10(3):e0168821.